Sonoma shareholders elect Jerry McLaughlin director, approve pay and auditor

Sonoma Pharmaceuticals, Inc.

Class III director Jerry McLaughlin elected with 336,722 for, 20,198 withheld.
Advisory executive-compensation vote passed: 286,312 for, 38,559 against, 32,049 abstain.
Ratification of Frazier & Deeter as auditor approved: 2,063,173 for, 12,522 against.
Adjournment proposal approved: 1,797,076 for, 119,486 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.